{"id":"NCT01028391","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)","officialTitle":"A 30-Week Extension to: A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Initial Therapy With Coadministration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09-01","primaryCompletion":"2009-01-01","completion":"2009-01-01","firstPosted":"2009-12-09","resultsPosted":"2010-02-10","lastUpdate":"2017-05-12"},"enrollment":317,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Sitagliptin 100 mg q.d.+ Pioglitazone 45 mg q.d.","otherNames":[]},{"type":"DRUG","name":"Pioglitazone 45 mg q.d. + Sitagliptin 100 mg placebo q.d.","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]}],"arms":[{"label":"Sitagliptin + Pioglitazone","type":"EXPERIMENTAL"},{"label":"Pioglitazone + Placebo","type":"ACTIVE_COMPARATOR"}],"summary":"A 30-week extension to a 24-week study assessing the hemoglobin A1c (HbA1c)- and fasting plasma glucose (FPG)-lowering efficacy of the combination of sitagliptin and pioglitazone in patients with type 2 diabetes mellitus (T2DM) with inadequate glycemic control.","primaryOutcome":{"measure":"Change From Baseline (i.e., Week 0 of the 24-week Base Study) in Hemoglobin A1c (HbA1c) at Week 54","timeFrame":"Baseline and 54 Weeks","effectByArm":[{"arm":"Sitagliptin 100 mg q.d. + Pioglitazone 45 mg q.d.","deltaMin":-2.37,"sd":null},{"arm":"Pioglitazone 45 mg q.d.","deltaMin":-1.86,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21235696","22405352"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":164},"commonTop":["All Infections and Infestations","Nasopharyngitis"]}}